US · Healthcare · Diagnostics & Research
EPS came in at 0.18 against a street estimate of 0.17 — a beat of 5.9%.
Analysts rate Sotera Health Co a buy (5 buy, 3 hold, 0 sell out of 8) with an average price target of $20.44.
| Fund | Stake |
|---|---|
| Darsana Capital Partners LP | 9.12% |
| Sessa Capital, L.P | 8.08% |
| OZ Management LLC | 7.62% |
| BlackRock Inc | 7.31% |
| Warburg Pincus LLC | 6.70% |
| GTCR LLC | 4.47% |
| Sachem Head Capital Management LP | 4.08% |
| Vanguard Capital Management, LLC | 3.76% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 2026 | 2026-05-22 |
| Material agreement · Q2 2026 | 2026-05-20 |
| Company announcement · Q2 2026 | 2026-05-13 |
| Quarterly report · Q1 2026 | 2026-05-05 |
| Results announced · Q2 2026 | 2026-05-05 |
| Proxy statement · Q2 2026 | 2026-04-08 |
| Annual report FY2025 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-11-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Sotera Health Co — free to start.
Google PlayApp StoreData updated 2026-08-05.